Literature DB >> 20818820

Association of NOD1 (CARD4) insertion/deletion polymorphism with susceptibility to IBD: a meta-analysis.

Wei-Guo Lu1, Yan-Feng Zou, Xiao-Liang Feng, Feng-Lai Yuan, Yuan-Long Gu, Xia Li, Cheng-Wan Li, Cheng Jin, Jian-Ping Li.   

Abstract

AIM: To find evidences about whether NOD1/CARD4 insertion/deletion polymorphism is associated with inflammatory bowel disease by meta-analysis.
METHODS: We surveyed the studies on the association of NOD1/CARD4 insertion/deletion polymorphism with inflammatory bowel disease in PubMed. Meta-analysis was performed for genotypes GG/T vs T/T, GG/GG vs T/T, GG/T + GG/GG vs T/T, GG/GG vs T/T + GG/T, and GG allele vs T allele in a fixed/random effect model.
RESULTS: We identified 8 studies (6439 cases and 4798 controls) in Caucasian populations using PubMed search. We found no association between NOD1/CARD4 insertion/deletion polymorphism and inflammatory bowel disease, Crohn's disease, and ulcerative colitis. Stratification of cases by age showed that NOD1/CARD4 insertion/deletion polymorphism was associated with inflammatory bowel disease in younger age group at onset (< 40 years) (GG vs T: OR = 0.68, 95% CI: 0.50-0.93, P = 0.02; GG/T + GG/GG vs T/T: OR = 0.71, 95% CI: 0.59-0.85, P = 0.0003).
CONCLUSION: This meta-analysis demonstrates an association between NOD1/CARD4 insertion/deletion polymorphism and inflammatory bowel disease in the younger age group at onset (< 40 years) in Caucasian populations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20818820      PMCID: PMC2937117          DOI: 10.3748/wjg.v16.i34.4348

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  44 in total

1.  CARD4/NOD1 is not involved in inflammatory bowel disease.

Authors:  H Zouali; S Lesage; F Merlin; J-P Cézard; J-F Colombel; J Belaiche; S Almer; C Tysk; C O'Morain; M Gassull; S Christensen; Y Finkel; R Modigliani; C Gower-Rousseau; J Macry; M Chamaillard; G Thomas; J-P Hugot
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

3.  NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.

Authors:  T Molnar; P Hofner; F Nagy; P L Lakatos; S Fischer; L Lakatos; A Kovacs; I Altorjay; M Papp; K Palatka; P Demeter; Z Tulassay; T Nyari; P Miheller; J Papp; Y Mandi; J Lonovics
Journal:  Dig Liver Dis       Date:  2007-10-26       Impact factor: 4.088

4.  Influence of a nucleotide oligomerization domain 1 (NOD1) polymorphism and NOD2 mutant alleles on Crohn's disease phenotype.

Authors:  Elisabet Cantó; Elena Ricart; David Busquets; David Monfort; Esther García-Planella; Dolors González; Joaquim Balanzó; José-L Rodriguez-Sanchez; Sílvia Vidal
Journal:  World J Gastroenterol       Date:  2007-11-07       Impact factor: 5.742

Review 5.  Signalling pathways and molecular interactions of NOD1 and NOD2.

Authors:  Warren Strober; Peter J Murray; Atsushi Kitani; Tomohiro Watanabe
Journal:  Nat Rev Immunol       Date:  2006-01       Impact factor: 53.106

6.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

Review 7.  Etiology of the inflammatory bowel diseases.

Authors:  J P Hugot; H Zouali; S Lesage; G Thomas
Journal:  Int J Colorectal Dis       Date:  1999-02       Impact factor: 2.571

Review 8.  Immune response versus mucosal tolerance to mucosally administered antigens.

Authors:  Jiri Mestecky; Zina Moldoveanu; Charles O Elson
Journal:  Vaccine       Date:  2005-03-07       Impact factor: 3.641

9.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

Review 10.  Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation.

Authors:  Mathias Chamaillard; Stephen E Girardin; Jérôme Viala; Dana J Philpott
Journal:  Cell Microbiol       Date:  2003-09       Impact factor: 3.715

View more
  18 in total

Review 1.  Effector functions of NLRs in the intestine: innate sensing, cell death, and disease.

Authors:  Garabet Yeretssian
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

Review 2.  Emerging significance of NLRs in inflammatory bowel disease.

Authors:  Beckley K Davis; Casandra Philipson; Raquel Hontecillas; Kristin Eden; Josep Bassaganya-Riera; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

Review 3.  Innate immune signalling at the intestinal epithelium in homeostasis and disease.

Authors:  Johanna Pott; Mathias Hornef
Journal:  EMBO Rep       Date:  2012-07-17       Impact factor: 8.807

4.  Structure and functional characterization of the RNA-binding element of the NLRX1 innate immune modulator.

Authors:  Minsun Hong; Sung-il Yoon; Ian A Wilson
Journal:  Immunity       Date:  2012-03-01       Impact factor: 31.745

5.  Nod/Ripk2 signaling in dendritic cells activates IL-17A-secreting innate lymphoid cells and drives colitis in T-bet-/-.Rag2-/- (TRUC) mice.

Authors:  Joerg Ermann; Tracy Staton; Jonathan N Glickman; Rene de Waal Malefyt; Laurie H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-09       Impact factor: 11.205

6.  NOD1 in contrast to NOD2 functional polymorphism influence Chlamydia trachomatis infection and the risk of tubal factor infertility.

Authors:  Ivan Branković; Eleanne F van Ess; Marlies P Noz; Wilhelmina Anke J Wiericx; Joke Spaargaren; Servaas A Morré; Sander Ouburg
Journal:  Pathog Dis       Date:  2015-01-11       Impact factor: 3.166

Review 7.  New insights into Nod-like receptors (NLRs) in liver diseases.

Authors:  Tao Xu; Yan Du; Xiu-Bin Fang; Hao Chen; Dan-Dan Zhou; Yang Wang; Lei Zhang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2018-03-10

Review 8.  The role of bacteria and pattern-recognition receptors in Crohn's disease.

Authors:  Si Ming Man; Nadeem O Kaakoush; Hazel M Mitchell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02-08       Impact factor: 46.802

Review 9.  NOD1 and NOD2 in inflammatory and infectious diseases.

Authors:  Bruno C Trindade; Grace Y Chen
Journal:  Immunol Rev       Date:  2020-07-17       Impact factor: 12.988

10.  Polymorphisms in Toll-like receptors 2, 4, and 9 are highly associated with hearing loss in survivors of bacterial meningitis.

Authors:  Gijs Th J van Well; Marieke S Sanders; Sander Ouburg; A Marceline van Furth; Servaas A Morré
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.